Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Gilead

Millions will die in coming years if US funding for HIV programmes is not replaced, UN warns

US cuts could lead to four million AIDS-related deaths by 2029, according to UN officials.

Euronews

UN says if US funding for HIV programs is not replaced, millions more will die by 2029

A new U.N. AIDS agency report says the sudden withdrawal of U.S. funding has caused a “systemic shock” to the global effort against AIDS and HIV

The Independent UK

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and deserve attention.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

US approves breakthrough HIV jab – but aid cuts mean it may not get to millions in need

FDA approval paves the way for the jab to roll out across the world. But with funding being slashed, will it get to the people who need it? Rachel Schraer reports

The Independent UK

Marjorie Taylor Greene Buys Stocks Focusing on Tech, Energy, and a Biotech Firm That Recently Received FDA Approval for HIV Drug

US Congress member Marjorie Taylor Greene purchased shares of Adobe, Netflix, Snowflake, ServiceNow, NextEra Energy, and Gilead Sciences on 6th June.

International Business Times UK

Groundbreaking twice-a-year HIV drug that could stop transmission approved

It's unclear how many people in the US and abroad will get access to the powerful new HIV prevention medication

The Independent UK

US Approves Gilead's Twice-yearly Injection To Prevent HIV

The US Food and Drug Administration on Wednesday approved Gilead Sciences' twice-yearly injection to prevent HIV -- a move the company hailed as a major breakthrough in the fight against the sexually transmitted virus.

International Business Times

Read news from The Economist, FT, and more,
with one subscription

Here’s what to know about the twice-yearly preventative HIV shot

A twice-yearly drug called lenacapavir is now the longest-lasting type of PrEP

The Independent UK

‘HIV-ending’ drug could be made for just $25 per patient a year, say researchers

As regulator prepares to approve Lenacapavir in the US, campaigners are urging the manufacturer, Gilead, to make it ‘available and affordable for all who need it’

The Guardian - UK

Millions of doses of ‘pandemic-ending’ HIV jab at risk over Trump’s aid cuts

INTERVIEW: The funding for 2 million people to receive the twice-yearly preventative treatment lenacapavir is ‘receding in the chaos’ of the US president’s decision, the doctor behind the trial of the drug tells Rachel Schraer

The Independent UK

'The Handmaid's Tale's Ending Brought The Show Back To Its Worst Habits

The series finally ended, but not without going back to its most annoying trope.

Inverse

Unusual Options Alert: The Smart Money is Piling Into Gilead Sciences (GILD)

While the new political paradigm might not be the most conducive environment for Gilead Sciences, positive sentiment is brewing for GILD stock.

Barchart

Handmaid’s Tale star breaks down episode 1’s shock reunion

Emotional scene is part of how the show will end

The Independent UK

3 Biotech Giants Gaining From U.S. Sales and Policy Shifts

The significant domestic revenue base of select US biotech companies offers stability potential for investors navigating global trade complexities.

MarketBeat

Get all your
news in one place.

100's of premium titles.
One news app.

Woman & Home

Why does Serena wear pink in The Handmaid's Tale season 6?

There's a status and outfit change for one of Gilead's most feared former Wives in season 6

Medical Daily

Doctors Pushed HIV Meds On Patients in Exchange For Lavish Meals, Trips, and Cash: Prosecutors

A pharmaceutical company that paid doctors kickbacks to push their HIV/AIDS drugs has agreed to pay a fine of more than $200 million.

Woman & Home

Does Janine die in The Handmaid's Tale?

She's been through so much and had quite the journey throughout each series of The Handmaid's Tale - and fans want to know the fate of Janine

Total Film

6 new movies and shows to watch this weekend on Netflix, Prime, Disney Plus, and more (April 18 - 20)

The Last of Us season 2 and award-winning movie Conclave are among this week's best streaming releases

Get all your
news in one place.

100's of premium titles.
One news app.

Woman & Home

Where is New Bethlehem in The Handmaid's Tale? The fictional place and real-life filming locations explored

New Bethlehem features a lot in season 6 of The Handmaid's Tale - we reveal where it could sit within the show's geography as well as the real-life filming location.

Barchart

Here's What to Expect From Gilead Sciences’ Next Earnings Report

Gilead Sciences is expected to announce its fiscal first-quarter earnings this month, and analysts forecast a robust triple-digit in its earnings.

The Independent UK

Handmaid’s Tale fans ‘cannot believe’ ending of first episode of season six: ‘It was worth the wait’

Hulu’s hit dystopian show is airing its final season in the U.S.

Tom’s Guide

10 top new movies and shows to stream this weekend on Netflix, Max and more (April 11-13)

'The White Lotus' finale, 'Dying for Sex' and 'Black Bag' lead my weekend watch list

Salon

"The Handmaid's Tale": America's finale

We've watched June run in and out of Gilead and now we're running with her

Evening Standard

The Handmaid’s Tale season 6: UK release date, cast, plot and how to watch

Fans can expect the final instalment to deliver the ultimate showdown between the rebels, led by Elizabeth Moss’s June, and Gilead

The Independent UK

Praise be, loyal ‘Handmaid’s Tale’ fans: Propulsive final season promises a satisfying catharsis

Praise be

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.